Physician

Nicholas Anthony Iafe, MD

According to 2025 Medicare claims, Nicholas Iafe, MD (NPI: 1942733811) practices ophthalmology in the St. Louis, MO-IL market, with the plurality of this provider's patient population coming from St. Louis, MO. This provider's primary affiliated billing organization is RETINA CONSULTANTS, LLC (NPI: 1700175395; TIN: 430913832) and primary practice location at 62034-1702.

Iafe's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 975 traditional Medicare patients, billed 26,150 HCPCS/CPT codes, and received $2,229,137 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 804 prescription claims across 253 beneficiaries totaling $29,650 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 38 records totaling $3,193. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $1,364 to $29,650. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.2M2021 Medicare payment: $24,445 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $10,677 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $444,769 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,229,137 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021160209$24,445
202299113$10,677
20235803,839$444,769
202497526,150$2,229,137

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$15K$30K2017 Drug cost: $1,364 (USD; Tot_Drug_Cst)2018 Drug cost: $6,840 (USD; Tot_Drug_Cst)2019 Drug cost: $20,819 (USD; Tot_Drug_Cst)2020 Drug cost: $6,827 (USD; Tot_Drug_Cst)2021 Drug cost: $21,522 (USD; Tot_Drug_Cst)2022 Drug cost: $14,113 (USD; Tot_Drug_Cst)2023 Drug cost: $26,517 (USD; Tot_Drug_Cst)2024 Drug cost: $29,650 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171228$1,364
201837164$6,840
201948158$20,819
202032115$6,827
2021107286$21,522
202284242$14,113
2023165511$26,517
2024253804$29,650

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye3281,254$87
92014Established patient complete exam of visual system562682$84
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more328440$61
92134Imaging of retina9472,601$28
92202Extended exam of the back part of the eye with optic nerve drawing6131,030$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate2298,924$8,770
Bromfenac SodiumBromfenac Sodium27584$4,183
Ketorolac TromethamineKetorolac Tromethamine1925,682$3,620
DifluprednateDifluprednate16479$2,050
MoxifloxacinMoxifloxacin Hcl841,296$1,712

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.38$3,193EyePoint Pharmaceuticals US, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Nicholas Anthony Iafe, MD?

Tedicare shows public-source Medicare data for Nicholas Anthony Iafe, MD (NPI 1942733811), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nicholas Anthony Iafe, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nicholas Anthony Iafe, MD?

Nicholas Anthony Iafe, MD is linked to RETINA CONSULTANTS, LLC (billing NPI 1700175395) in the available physician profile data.

Does Nicholas Anthony Iafe, MD have Open Payments data?

Nicholas Anthony Iafe, MD has 38 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.